JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB201798

DyLight® 405偶联试剂盒(Fast) - Lightning-Link®

Be the first to review this product! Submit a review

|

(11 Publications)

DyLight® 405 Conjugation Kit (Fast) - Lightning-Link® (ab201798) offers several standout features:

- Rapid Conjugation: achieve DyLight® 405 labeling in under 20 minutes with just 30 seconds of hands-on time.
- High Efficiency: ensures 100% antibody recovery, meaning no loss of valuable antibodies.
- Versatility: suitable for conjugating antibodies, proteins, and peptides. DyLight® 405 labeled antibodies can be used immediately in applications such as Western blot (WB), ELISA, and Immunohistochemistry (IHC) without further purification.
3 Images
Schematic Diagram - DyLight® 405 Conjugation Kit (Fast) - Lightning-Link® (AB201798)
  • Schematic Diagram

Supplier Data

This illustration demonstrates a general procedure of how the Lightning-Link®(Fast) labeling technology enables the direct labeling of antibodies or proteins.

Simply pipette your antibody or biomolecule of choice into the vial of a lyophilized mixture containing the label of interest and incubate for just 15 minutes. Please see the ab201798 protocol booklet for more details.

Learn more about our Lightning-Link® conjugation kits here

Other - DyLight® 405 Conjugation Kit (Fast) - Lightning-Link® (AB201798)
  • Other

Lab

Representative image of DyLight® 405 Conjugation Kit (Fast) - Lightning-Link® (ab201798)

Components shown from left to right :

DyLight® 405 mix (3 vials for 3x 10 µg, 3x 100 µg)

Modifier reagent (1 vial)

Quencher reagent (1 vial)

Securitainer

Note : The vial labels shown in this image use generic names for illustrative purposes only and may not exactly match the specific component names included in the conjugation kit.

Note : Color of the lyophilized material in image may not precisely match the color shade in the actual kit.

Other - DyLight® 405 Conjugation Kit (Fast) - Lightning-Link® (AB201798)
  • Other

Lab

Representative image of DyLight® 405 Conjugation Kit (Fast) - Lightning-Link® (ab201798)

Components shown from left to right :

DyLight® 405 mix (1 vial for 100 µg, 1 mg)

Modifier reagent (1 vial)

Quencher reagent (1 vial)

Securitainer

Note : The vial labels shown in this image use generic names for illustrative purposes only and may not exactly match the specific component names included in the conjugation kit.

Note : Color of the lyophilized material in image may not precisely match the color shade in the actual kit.

关键信息

产品详情

DyLight® 405 Conjugation Kit (Fast) - Lightning-Link® (ab201798) uses a simple and quick process for DyLight® 405 labeling / conjugation of antibodies. It can also be used to conjugate other proteins or peptides.

To conjugate an antibody to DyLight® 405 using this kit:
- add modifier to antibody and incubate for 15 min
- add quencher and incubate for 5 min

The DyLight® 405 conjugated antibody can be used immediately in Flow cytometry, WB, ELISA, IHC etc. No further purification is required and 100% of the antibody is recovered for use.

Learn about our antibody labeling kits and their advantages here.

Learn about buffer compatibility below; for incompatible buffers and low antibody concentrations, use our antibody purification and concentration kits.
Custom size conjugation kits up to 100 mg are available on demand. Please contact us to discuss your requirements.

Amount and volume of antibody for conjugation to DyLight® 405

Kit size Recommended
amount of antibody1
Maximum
amount of antibody
Maximum antibody
volume2
3 x 10 µg 3 x 10 µg 3 x 20 µg 3 x 10 µL
100 µg 1 x 100 µg 1 x 200 µg 1 x 100 µ
3 x 100 µg 3 x 100 µ 3 x 200 µg 3 x 100 µL
1 mg 1 x 1 mg 1 x 2 mg 1 x 1 mL

1 Using the maximum amount of antibody may result in less labelling per antibody.
2 Ideal antibody concentration is 1 mg/mL. 0.5 - 1 mg/mL can be used if the maximum antibody volume is not exceeded. Antibodies > 2 mg/mL or < 0.5 mg/mL should be diluted /concentrated.

Buffer Requirements for Conjugation

Buffer should be pH 6.5-8.5.

Compatible buffer constituents
If a concentration is shown, then the constituent should be no more than the concentration shown. If several constituents are close to the limit of acceptable concentration, then this can inhibit conjugation.

50mM / 0.6% Tris1 0.1% BSA2 50% glycerol
0.1% sodium azide3 PBS Potassium phosphate
Sodium chloride HEPES Sucrose
Sodium citrate EDTA Trehalose

1 Tris buffered saline is almost always ≤ 50 mM / 0.6%
2 BSA can also interfere with the use of the conjugated antibody in tissue staining.

Incompatible buffer constituents

Thiomerosal Proclin Glycine
Arginine Glutathione DTT

If a constituent of the buffer containing your antibody or protein is not listed above, please contact us.

Only purified antibodies are suitable for use, ie. where other proteins, peptides, or amino acids are not present: antibodies in ascites fluid, serum or hybridoma culture media are incompatible.

Storing and handling conjugation kits

Lyophilized Lightning-Link® components are hygroscopic.

Kits are intentionally shipped at ambient temperature with silica gel to avoid exposure to moisture. Upon receipt, store the kit frozen and protect from moisture. Before opening the outer container, allow the lyophilized components to reach room temperature to minimize condensation.

DyLight® is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.

This product is manufactured by Expedeon, an Abcam company, and was previously called Lightning-Link® Rapid DyLight® 405 Labeling Kit. 321-0015 is the same as the 1 mg size. 321-0010 is the same as the 3 x 100 µg size. 321-0030 is the same as the 3 x 10 µg size. 321-0005 is the same as the 100 µg size.

规格

{ "values": { "3x10g": { "sellingSize": "3 x 10 µg", "publicAssetCode":"ab201798-3x10ug", "assetComponentDetails": [ { "size":"3 x 10 µg", "name":"Dylight® 405 Conjugation Mix", "number":"AB201798-CMP01" }, { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB201798-CMP03" }, { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB201798-CMP02" } ] }, "3x100g": { "sellingSize": "3 x 100 µg", "publicAssetCode":"ab201798-3x100ug", "assetComponentDetails": [ { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB201798-CMP02" }, { "size":"3 x 100 µg", "name":"Dylight® 405 Conjugation Mix", "number":"AB201798-CMP01" }, { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB201798-CMP03" } ] }, "1mg": { "sellingSize": "1 mg", "publicAssetCode":"ab201798-1mg", "assetComponentDetails": [ { "size":"1 x 1 mg", "name":"Dylight® 405 Conjugation Mix", "number":"AB201798-CMP01" }, { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB201798-CMP02" }, { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB201798-CMP03" } ] }, "100g": { "sellingSize": "100 µg", "publicAssetCode":"ab201798-100ug", "assetComponentDetails": [ { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB201798-CMP02", "productcode":"" }, { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB201798-CMP03", "productcode":"" }, { "size":"1 x 100 µg", "name":"Dylight® 405 Conjugation Mix", "number":"AB201798-CMP01", "productcode":"" } ] } } }

性能和储存信息

运输条件
Ambient - Cannot Ship with Ice
推荐的短期储存条件
-20°C
推荐的长期储存条件
-20°C
储存信息
-20°C

产品实验方案

靶点信息

文献 (11)

Recent publications for all applications. Explore the full list and refine your search

Nature 644:790-798 PubMed40533564

2025

Kupffer cell programming by maternal obesity triggers fatty liver disease.

Applications

Unspecified application

Species

Unspecified reactive species

Hao Huang,Nora R Balzer,Lea Seep,Iva Splichalova,Nelli Blank-Stein,Maria Francesca Viola,Eliana Franco Taveras,Kerim Acil,Diana Fink,Franzisca Petrovic,Nikola Makdissi,Seyhmus Bayar,Katharina Mauel,Carolin Radwaniak,Jelena Zurkovic,Amir H Kayvanjoo,Klaus Wunderling,Malin Jessen,Mohamed H Yaghmour,Lukas Kenner,Thomas Ulas,Stephan Grein,Joachim L Schultze,Charlotte L Scott,Martin Guilliams,Zhaoyuan Liu,Florent Ginhoux,Marc D Beyer,Christoph Thiele,Felix Meissner,Jan Hasenauer,Dagmar Wachten,Elvira Mass

The Journal of clinical investigation 134: PubMed38954588

2024

Inhibiting the NADase CD38 improves cytomegalovirus-specific CD8+ T cell functionality and metabolism.

Applications

Unspecified application

Species

Unspecified reactive species

Nils Mülling,Felix M Behr,Graham A Heieis,Kristina Boss,Suzanne van Duikeren,Floortje J van Haften,Iris N Pardieck,Esmé Ti van der Gracht,Ward Vleeshouwers,Tetje C van der Sluis,J Fréderique de Graaf,Dominique Mb Veerkamp,Kees Lmc Franken,Xin Lei,Lukas van de Sand,Sjoerd H van der Burg,Marij Jp Welters,Sebastiaan Heidt,Wesley Huisman,Simon P Jochems,Martin Giera,Oliver Witzke,Aiko Pj de Vries,Andreas Kribben,Bart Everts,Benjamin Wilde,Ramon Arens

Nature communications 14:5627 PubMed37699869

2023

Metabolic heterogeneity of tissue-resident macrophages in homeostasis and during helminth infection.

Applications

Flow Cyt (Intra)

Species

Mouse

Graham A Heieis,Thiago A Patente,Luís Almeida,Frank Vrieling,Tamar Tak,Georgia Perona-Wright,Rick M Maizels,Rinke Stienstra,Bart Everts

Pain 164:1965-1975 PubMed37027145

2023

Local analgesia of electroacupuncture is mediated by the recruitment of neutrophils and released β-endorphins.

Applications

Unspecified application

Species

Unspecified reactive species

Jing-Tao Shi,Wan-Ying Cao,Xiao-Ning Zhang,Hong-Ye Wan,Yang-Shuai Su,Zheng-Yang Qu,Rui Wang,Wei He,Xiang-Hong Jing,Xiao-Yu Wang

Nature communications 14:1944 PubMed37029141

2023

Booster with Ad26.COV2.S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques.

Applications

Unspecified application

Species

Unspecified reactive species

Laura Solforosi,Lea M M Costes,Jeroen T B M Tolboom,Katherine McMahan,Tochi Anioke,David Hope,Tetyana Murdza,Michaela Sciacca,Emily Bouffard,Julia Barrett,Cindy Wu,Nicole Hachmann,Jessica Miller,Jingyou Yu,Xuan He,Catherine Jacob-Dolan,Sietske K Rosendahl Huber,Liesbeth Dekking,Ronnie Chamanza,Ying Choi,Karin Feddes-de Boer,Dan H Barouch,Hanneke Schuitemaker,Roland C Zahn,Frank Wegmann

iScience 26:106514 PubMed37091227

2023

Semi-supervised analysis of myeloid and T cell behavior in ovarian tumor slices reveals changes in cell motility after treatments.

Applications

Unspecified application

Species

Unspecified reactive species

Florian Laforêts,Panoraia Kotantaki,Beatrice Malacrida,Samar Elorbany,Ranjit Manchanda,Emmanuel Donnadieu,Frances Balkwill

Breast cancer research : BCR 25:23 PubMed36859337

2023

Lineage plasticity enables low-ER luminal tumors to evolve and gain basal-like traits.

Applications

Unspecified application

Species

Unspecified reactive species

Gadisti Aisha Mohamed,Sundis Mahmood,Nevena B Ognjenovic,Min Kyung Lee,Owen M Wilkins,Brock C Christensen,Kristen E Muller,Diwakar R Pattabiraman

Current protocols 2:e584 PubMed36383032

2022

Evaluating the Clinical and Immune Responses to Spotted Fever Rickettsioses in the Guinea Pig-Tick-Rickettsia System.

Applications

Unspecified application

Species

Unspecified reactive species

John V Stokes,Michael L Levin,Claire E Cross,Anne-Marie L Ross,Alyssa N Snellgrove,Bridget V Willeford,Navatha Alugubelly,Andrea S Varela-Stokes

Journal of immunology (Baltimore, Md. : 1950) 201:3804-3814 PubMed30413671

2018

Multiplexed FluoroSpot for the Analysis of Dengue Virus- and Zika Virus-Specific and Cross-Reactive Memory B Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Awadalkareem Adam,Marcia Woda,Sonia Kounlavouth,Alan L Rothman,Richard G Jarman,Josephine H Cox,Julie E Ledgerwood,Gregory D Gromowski,Jeffrey R Currier,Heather Friberg,Anuja Mathew

Cell reports 20:1073-1087 PubMed28768193

2017

Immunogenetic Profiling for Gastric Cancers Identifies Sulfated Glycosaminoglycans as Major and Functional B Cell Antigens in Human Malignancies.

Applications

Unspecified application

Species

Unspecified reactive species

Hiroto Katoh,Daisuke Komura,Hiroki Konishi,Ryohei Suzuki,Asami Yamamoto,Miwako Kakiuchi,Reiko Sato,Tetsuo Ushiku,Shogo Yamamoto,Kenji Tatsuno,Takashi Oshima,Sachiyo Nomura,Yasuyuki Seto,Masashi Fukayama,Hiroyuki Aburatani,Shumpei Ishikawa
View all publications
websiteProtocolBooklet
en
websiteProtocolBooklet
zh

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com